
Board Meeting29 Oct 2026, 06:00 pm
Fermenta Biotech Board Meeting on Nov 5 for Unaudited Results
AI Summary
Fermenta Biotech Ltd has announced that its Board of Directors will convene on November 5, 2026, to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026. The company has also informed about the closure of the trading window from October 1, 2026, until 48 hours after the declaration of these results, restricting trading by directors, promoters, and designated persons.
Key Highlights
- Board meeting scheduled for November 5, 2026.
- To approve unaudited financial results for Q2 FY27.
- Results will be standalone and consolidated.
- Trading window closed from October 1, 2026.
- Restrictions apply to directors, promoters, and insiders.
Price Impact
More from FERMENTA